[HTML][HTML] A cost-benefit analysis of the COVID-19 asymptomatic mass testing strategy in the north Metropolitan area of Barcelona

F López Seguí, O Estrada Cuxart… - International journal of …, 2021 - mdpi.com
Background: The epidemiological situation generated by COVID-19 has highlighted the
importance of applying non-pharmacological measures in the management of the epidemic …

[PDF][PDF] A Cost-Benefit Analysis of the COVID-19 Asymptomatic Mass Testing Strategy in the North Metropolitan Area of Barcelona

F López Seguí, O Estrada Cuxart… - Int. J. Environ. Res …, 2021 - researchgate.net
Background: The epidemiological situation generated by COVID-19 has highlighted the
importance of applying non-pharmacological measures in the management of the epidemic …

[PDF][PDF] A Cost-Benefit Analysis of the COVID-19 Asymptomatic Mass Testing Strategy in the North Metropolitan Area of Barcelona

F López Seguí, O Estrada Cuxart… - Int. J. Environ. Res …, 2021 - pdfs.semanticscholar.org
Background: The epidemiological situation generated by COVID-19 has highlighted the
importance of applying non-pharmacological measures in the management of the epidemic …

A Cost-Benefit Analysis of the COVID-19 Asymptomatic Mass Testing Strategy in the North Metropolitan Area of Barcelona

FL Seguí, OE Cuxart, OMI Villar… - … and public health, 2021 - pubmed.ncbi.nlm.nih.gov
Background The epidemiological situation generated by COVID-19 has highlighted the
importance of applying non-pharmacological measures in the management of the epidemic …

[PDF][PDF] A Cost-Benefit Analysis of the COVID-19 Asymptomatic Mass Testing Strategy in the North Metropolitan Area of Barcelona

FL Seguí, OE Cuxart, OM i Villar, GH Guillamet, N Prat… - 2021 - scholar.archive.org
Background: The epidemiological situation generated by COVID-19 has highlighted the
importance of applying non-pharmacological measures in the management of the epidemic …

A cost-benefit analysis of the COVID-19 asymptomatic mass testing strategy in the north metropolitan area of Barcelona.

FL Seguí, OE Cuxart, OMI Villar, GH Guillamet, NP Gil… - 2021 - cabidigitallibrary.org
Background: The epidemiological situation generated by COVID-19 has highlighted the
importance of applying non-pharmacological measures in the management of the epidemic …

[HTML][HTML] A Cost-Benefit Analysis of the COVID-19 Asymptomatic Mass Testing Strategy in the North Metropolitan Area of Barcelona

FL Seguí, OE Cuxart, OM i Villar… - … Research and Public …, 2021 - ncbi.nlm.nih.gov
Background: The epidemiological situation generated by COVID-19 has highlighted the
importance of applying non-pharmacological measures in the management of the epidemic …

A Cost-Benefit Analysis of the COVID-19 Asymptomatic Mass Testing Strategy in the North Metropolitan Area of Barcelona

FL Seguí, OE Cuxart, OM i Villar… - … and Public Health, 2021 - search.proquest.com
Background: The epidemiological situation generated by COVID-19 has highlighted the
importance of applying non-pharmacological measures in the management of the epidemic …

A Cost-Benefit Analysis of the COVID-19 Asymptomatic Mass Testing Strategy in the North Metropolitan Area of Barcelona.

M Bonet, I Blanco, AP JM, B Clotet… - International Journal of …, 2021 - europepmc.org
Background: The epidemiological situation generated by COVID-19 has highlighted the
importance of applying non-pharmacological measures in the management of the epidemic …

A Cost-Benefit Analysis of the COVID-19 Asymptomatic Mass Testing Strategy in the North Metropolitan Area of Barcelona

FL Seguí, OE Cuxart, OM i Villar, GH Guillamet, NP Gil… - IJERPH, 2021 - agris.fao.org
Background: The epidemiological situation generated by COVID-19 has highlighted the
importance of applying non-pharmacological measures in the management of the epidemic …